DYNE THERAPEUTICS INC. - COMMON STOCK
29.89
25-November-24 14:07:12
15 minutes delayed
Stocks
+0.20
+0.67%
Today's range
29.19 - 30.77
ISIN
N/A
Source
NASDAQ
-
Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
13 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at February Investor Conferences
01 Feb 2024 07:30:00 By Nasdaq GlobeNewswire
-
11 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
05 Jan 2024 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock
04 Jan 2024 22:46:36 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
03 Jan 2024 16:25:00 By Nasdaq GlobeNewswire
-
02 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at November Investor Conferences
07 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
30 Oct 2023 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at October Investor Conferences
28 Sep 2023 07:30:00 By Nasdaq GlobeNewswire
-
20 Sep 2023 16:05:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
05 Sep 2023 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
03 Aug 2023 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Healthcare Conference
01 Jun 2023 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101
25 May 2023 07:30:00 By Nasdaq GlobeNewswire
-
17 May 2023 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
11 May 2023 07:30:00 By Nasdaq GlobeNewswire